Analysts / Institutional Investor Meet - Intimation
Neuland Laboratories Ltd has informed BSE regarding "Analysts / Institutional Investor Meet - Intimation".19-08-2016
Analysts / Institutional Investor Meet - Intimation
Neuland Laboratories Ltd has informed BSE regarding "Analysts / Institutional Investor Meet - Intimation".Updates on Outcome of AGM
Neuland Laboratories Ltd has submitted to BSE a copy of proceedings of the Annual General Meeting (AGM) of the Company held on August 12, 2016.We expect margins to touch 20% in medium to long term: D Sucheth Rao, VC & CEO, Neuland Labs
"About four or five years ago our EBITDA margins were hovering around 11 per cent to 12 per cent. Today they are at about 16-17 per cent.," said Rao.Revised Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Neuland Laboratories Ltd has informed BSE regarding the Revised details of Voting results at the Annual General Meeting (AGM) of the Company held on August 12, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015.Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Neuland Laboratories Ltd has informed BSE regarding the details of Voting results at the 32nd Annual General Meeting (AGM) of the Company held on August 12, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report and Proceedings of the Meeting in this regard.Outcome of AGM
Neuland Laboratories Ltd has informed BSE that the 32nd Annual General Meeting (AGM) of the Company was held on August 12, 2016.Results Press Release for June 30, 2016
Neuland Laboratories Ltd has informed BSE about : 1. Result Press Release for the period ended June 30, 2016Standalone Financial Results for June 30, 2016
Neuland Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 2016Results Release & Revised Earnings Call Notice
With reference to the earlier letter dated August 08, 2016, Neuland Laboratories Ltd has now informed BSE that there has been a change in the schedule of the Earnings Call. The Company has submitted to BSE a copy of Revised Earning Call details of Q1 FY 2017.Q1 FY 2017 Earnings Call
Neuland Laboratories Ltd has submiited to BSE a copy of the Q1 FY 2017 Earnings Call details.